Vancouver, British Columbia (FSCwire) - EVITRADE Health Systems Corp. (CSE:EVA,
OTCQB: AXHLF) (the “Company” or “EVITRADE”) announces that Friday March 3rd, 2017 is to be the new date for the Annual
General and Special Meeting (AGSM) and that the record date already set as of January 6th, 2017 will remain as the
record date for holders of record to vote at the upcoming AGSM. For more information please refer to the information
circular which is now in the process of being mailed to shareholders or posted at www.sedar.com.
Contact:
Syd Au, Chairman and CEO
EVITRADE Health Systems Corporation
(formerly Auxellence Health Corporation)
Email: ceo@auxellence.com
Website: http://www.auxellence.com
CSE Micro-site: http://thecse.com/en/listings/technology/evitrade-health-systems-corp
About EVITRADE Health Systems Corporation (CSE: EVA, OTCQB: AXHLD)
EVITRADE (formerly Auxellence Health Corp.), was founded in 2013 to provide online services for resolving common
health problems.
The company offers a physiologically interactive computing platform that integrates medical devices and artificial
intelligence applications into a fully automated, personal health management system for hypertension, arrhythmia, diabetes, and
obesity.
The current focus is on the normalization of cardiometabolic power in terms of blood pressure, blood glucose, and
body weight – and the monitoring of the physiological response to medical solicitations, mainly medication, diet, exercise, and
lifestyle changes.
About C&C Cosmeceuticals Corp. (wholly owned subsidiary of the Company)
C&C Cosmeceuticals Corp. was founded in 2011 to develop, manufacture and market nutraceutical and cosmeceutical
personal healthcare products and services. It was the predecessor company that acquired Auxellence Health Corporation,
which is now named EVITRADE Health Systems Corp. and is currently a wholly owned subsidiary. As per the September 2, 2016
press release from the parent company, and the follow up November 9,, 2016 press release from the parent company,
C&C is likely to be voted upon to be dividended or divested from the company and all shareholders on record as of will be
entitled to vote on that motion, at the Annual General and Special Meeting and any shareholders that are officially holders of
record for the dividend record date in the parent company are expected to receive a pro-rata distribution of the shares in the
subsidiary in the event the motion is successfully passed.
Disclaimers – Forward Looking Statements
This news release may contain forward-looking statements based on assumptions and judgments of management regarding
future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or
results to differ materially from those reflected in the forward looking statements. The company disclaims any intention or
obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its
business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings
with Canadian securities regulators which is posted on www.sedar.com, and http://thecse.com/en/listings/technology/evitrade-health-systems-corp.
This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities
described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX
Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the
adequacy or accuracy of this release.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities
described herein in the United States. The securities described herein have not been registered under the United States
Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the
“United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the
U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
To view this press release as a PDF file, click onto the following link:
public://news_release_pdf/Evitrade02072017.pdf
Source: EVITRADE Health Systems Corp. (CSE:EVA, OTCQB:AXHLF)
To follow EVITRADE Health Systems Corp. on your favorite social media platform or financial websites, please click on the
icons below.
Maximum News Dissemination by FSCwire. http://www.fscwire.com
Copyright © 2017 Filing Services Canada Inc.